November 10, 2025

EBRAINS‑Neurotech accelerates brain technology

The EBRAINS‑Neurotech consortium, recently launched in the Netherlands, brings together nine leading research institutions under the coordination of the University of Amsterdam. Their shared goal is to develop a new generation of brain interfaces and implants that will provide deeper insight into brain function and offer novel treatments for neurological and psychiatric disorders.

Driving the next generation of brain technology

Neurotechnologies—such as brain‑computer interfaces (BCIs) that measure or influence brain activity—are advancing rapidly. Yet, many current systems remain limited: bulky, slow, or lacking precision. EBRAINS‑Neurotech aims to address these limitations through an integrated research infrastructure that unites hardware, software, neuroscience, and ethics. With €18.3 million in funding from the Dutch Research Council (NWO), the consortium will enable researchers to manage the full development cycle—from brain modeling to functional implants—within one cohesive platform.

A key role is played by the Centrum Wiskunde & Informatica (CWI). Its Machine Learning group is developing algorithms that compress large neural networks into highly efficient forms that can run on embedded, low-power neuromorphic chips. This work is essential for realizing compact, portable, and implantable brain technologies suitable for real-world use.

Smart systems for medical and embedded AI

The potential applications are wide-ranging. The technology could support treatment of conditions such as stroke, epilepsy, depression, Alzheimer’s, Parkinson’s, and paralysis. Through miniaturization and nanotechnology, future brain implants will be smaller, more powerful, and more accurate—comparable to cardiac pacemakers in function.

The infrastructure also incorporates optogenetics (activating neurons with light), large-scale brain activity measurements, and neuromorphic computing—where chips mimic brain-like processing in a far more energy-efficient way than traditional hardware. These innovations open new paths for medical AI systems and intelligent embedded devices.

Responsible innovation

Alongside technical development, the consortium places strong emphasis on ethical and societal concerns. Issues such as data privacy, algorithmic bias, safe stimulation methods, and public acceptance are built into the project’s foundation. This integrated approach ensures that future applications are not only smart, but also safe, transparent, and socially responsible.

Read the full news release from CWI

Related news

How can we help you?

Looking for partners to collaborate. Or looking for a certain expertise? Or would you like to locate your business in the Amsterdam Science Park? Drop us a line and we help you to find a perfect match.

For business inquiries contact

Petra Baarendse

Let's connect